Orexo has submitted its Vorvida digital therapy for the treatment of heavy drinking for approval by the FDA, setting up a possible launch in the second half of this year. The Swedish drugmaker ...

Orexo AB (ORXOY) faced setbacks with the FDA approval process for OX 124, requiring additional tests and manufacturing, leading to delays. The company experienced a decline in net revenues by 11.4 ...

anaphylaxis) with powder-based epinephrine. OX640 is based on Orexo´s proprietary drug delivery platform, AmorphOX®, and has demonstrated positive data in a phase 1 clinical study in healthy ...

Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces that the company has received a complete response letter (CRL) from the US Food and Drug Administration (FDA) regarding the New Drug ...

The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections (uUTIs). Orlynvah (sulopenem etzadroxil and probenecid) is a broad-spectrum ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...

The FDA has approved a new oral antibiotic to treat uncomplicated urinary tract infections. Orylnvah is a broad-spectrum oral penem antibiotic for women who have limited or no alternative ...

› Total net revenues of SEK 136.5 m (156.1) › EBITDA of SEK -0.7 m (-9.5) › Net earnings of SEK -41.9 m (-33.3) › US Commercial segment net revenues of SEK 131.0 m (140.4), in local ...

At-home test results for both COVID-19 and flu appear in approximately 15 minutes, according to the FDA. The Healgen test is for self-use by individuals 14 years or older, or for young children ...

anaphylaxis) with powder-based epinephrine. OX640 is based on Orexo´s proprietary drug delivery platform, AmorphOX®, and has demonstrated positive data in a phase 1 clinical study in healthy ...

› Net earnings of SEK -41.9 m (-33.3) › US Commercial segment net revenues of SEK 131.0 m (140.4), in local currency USD 12.6 m (13.0) › Cash flow from operating activities of SEK -13.4 m (-21.9), ...